CVC Capital Partners raised its offer to buy all of Italian pharmaceutical firm Recordati to €10.5 billion after coming under pressure to raise the bid
CVC faces growing shareholder opposition over its €10.7 billion plan to take Recordati private - FT
The revolt could complicate the deal, highlighting investor concerns over the valuation and terms of the proposed buyout.